Skip to content

MEDIFICE: what changed

BE 0757.632.950Other company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€29,898
2024 · €1,249+€28,649
Equity
€15,115
2024 · -€14,783+€29,898
Cash
€41,890
2024 · €44,694-€2,804
Balance sheet total
€965,567
2024 · €1.0m-€81,433

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€56,403

    down €56,403 (-100%), from €56,403 to €0

  • Tangible fixed assets -€20,322

    down €20,322 (-2.2%), from €942,737 to €922,416

    of which Land and buildings: -€15,564

Equity and liabilities
  • Debts after one year -€86,600

    down €86,600 (-8.8%), from €979,494 to €892,894

  • Trade debts -€60,006

    down €60,006 (-93.6%), from €64,088 to €4,082

  • Current portion of long-term debt +€40,911

    up €40,911 (+469%), from €8,719 to €49,630

  • Profit (loss) carried forward +€29,898

    up €29,898 (+52.7%), from -€56,783 to -€26,885

Income statement
  • Gross operating margin +€53,102

    up €53,102 (+129%), from €41,301 to €94,403

  • Depreciation +€16,746

    up €16,746 (+130%), from €12,865 to €29,611

  • Financial charges +€4,777

    up €4,777 (+18.0%), from €26,526 to €31,302

  • Other operating charges +€2,934

    up €2,934 (+444%), from €661 to €3,595

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €1,249
Gross operating margin +€53,102
Depreciation -€16,746
Other operating charges -€2,934
Financial income +€3
Financial charges -€4,777
Result 2025 €29,898
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€50,274
Investment -€7,389
Financing -€45,688
Cash 2024 €44,694
Net result for the year +€29,898
Depreciation +€29,611
Receivables within one year +€56,403
Deferred charges and accrued income +€5
Trade debts -€60,006
Other debts -€6,082
Accrued charges and deferred income +€446
Investment in fixed assets (net) -€7,389
Debts after one year -€86,600
Current portion of long-term debt +€40,911
Cash 2025 €41,890
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,047,000 €965,567 -€81,433 -7.8%
Fixed assets 21/28 €944,637 €922,416 -€22,222 -2.4%
Tangible fixed assets 22/27 €942,737 €922,416 -€20,322 -2.2%
Land and buildings 22 €920,601 €905,038 -€15,564 -1.7%
Furniture and vehicles 24 €22,136 €17,378 -€4,758 -21.5%
Financial fixed assets 28 €1,900 €0 -€1,900 -100%
Current assets 29/58 €102,362 €43,151 -€59,211 -57.8%
Amounts receivable within one year 40/41 €56,403 €0 -€56,403 -100%
Other amounts receivable 41 €56,403 €0 -€56,403 -100%
Cash at bank and in hand 54/58 €44,694 €41,890 -€2,804 -6.3%
Deferred charges and accrued income 490/1 €1,266 €1,261 -€5 -0.4%
Total equity and liabilities 10/49 €1,047,000 €965,567 -€81,433 -7.8%
Equity 10/15 -€14,783 €15,115 +€29,898
Contributions 10/11 €42,000 €42,000 = 0.0%
Profit (loss) carried forward 14 -€56,783 -€26,885 +€29,898 +52.7%
Amounts payable 17/49 €1,061,783 €950,452 -€111,330 -10.5%
Amounts payable after more than one year 17 €979,494 €892,894 -€86,600 -8.8%
Financial debts 170/4 €979,494 €892,894 -€86,600 -8.8%
Amounts payable within one year 42/48 €78,889 €53,712 -€25,177 -31.9%
Current portion of amounts payable after more than one year 42 €8,719 €49,630 +€40,911 +469%
Trade debts 44 €64,088 €4,082 -€60,006 -93.6%
Suppliers 440/4 €64,088 €4,082 -€60,006 -93.6%
Other amounts payable 47/48 €6,082 €0 -€6,082 -100%
Accrued charges and deferred income 492/3 €3,400 €3,846 +€446 +13.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €12,865 €29,611 +€16,746 +130%
Other operating charges 640/8 €661 €3,595 +€2,934 +444%
Gross operating margin 9900 €41,301 €94,403 +€53,102 +129%
Operating profit (loss) 9901 €27,775 €61,197 +€33,422 +120%
Financial income 75/76B - €3 +€3
Recurring financial income 75 - €3 +€3
Financial charges 65/66B €26,526 €31,302 +€4,777 +18.0%
Recurring financial charges 65 €26,526 €31,302 +€4,777 +18.0%
Profit (loss) for the period before taxes 9903 €1,249 €29,898 +€28,649 +2,293%
Profit (loss) for the period 9904 €1,249 €29,898 +€28,649 +2,293%
Profit (loss) for the period to be appropriated 9905 €1,249 €29,898 +€28,649 +2,293%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€19,654 to €24,492

Midpoint €21,670 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €15,115
Capitalised earnings €24,193 to €33,870
Indication €19,654 to €24,492

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€15,115
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€15,115

Capitalised earnings

net result for the year (9904)
2025
€29,898
2024
€1,249
2023
-€20,985
2022
-€4,830
2021
-€32,217
Average result
€3,387
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€24,193 / €28,225 / €33,870

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.